Patterns and mutational signatures of tandem base substitutions causing human inherited disease

Human Mutation

Volumn 34, Issue 8, 2013, Pages 1119-1130

  Chen, Jian Min ^a,b,c   Férec, Claude ^a,b,c,d   Cooper, David N ^e  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^d CHU MORVAN   (France)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer; CpG transitions; Hypermutability; Serial replication slippage

Indexed keywords

DINUCLEOTIDE; DNA POLYMERASE; MUTAGENIC AGENT;

ARTICLE; CANCER GENETICS; CPG ISLAND; DATA BASE; DNA DAMAGE; DNA REPLICATION; EXOME; GENE DELETION; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; GENETIC DISORDER; GENOME; HUMAN; MISSENSE MUTATION; MUTAGENESIS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

CANCER; CPG TRANSITIONS; HYPERMUTABILITY; SERIAL REPLICATION SLIPPAGE;

BASE SEQUENCE; EXOME; GENETIC DISEASES, INBORN; GENETIC VARIATION; GERM-LINE MUTATION; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; TANDEM REPEAT SEQUENCES;

EID: 84880510825     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22341     Document Type: Article

References (67)

1. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65.
2. Arana ME, Kunkel TA. 2010. Mutator phenotypes due to DNA replication infidelity. Semin Cancer Biol 20:304-311.
3. Argiris A, Karamouzis MV, Raben D, Ferris RL. 2008. Head and neck cancer. Lancet 371:1695-1709.
4. Averof M, Rokas A, Wolfe KH, Sharp PM. 2000. Evidence for a high frequency of simultaneous double-nucleotide substitutions. Science 287:1283-1286.
5. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, Cortes ML, Fernandez-Lopez JC, et al. 2012. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486:405-409.
6. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, et al. 2012. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 44:685-689.
7. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, Onofrio R, Carter SL, et al. 2011. The genomic complexity of primary human prostate cancer. Nature 470:214-220.
8. Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E, Ghosh P, Zhang H, Zeid R, et al. 2012. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485:502-506.
9. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128.
10. Buettner VL, Hill KA, Halangoda A, Sommer SS. 1999. Tandem-base mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age. Environ Mol Mutagen 33:320-324.
11. Campbell CD, Chong JX, Malig M, Ko A, Dumont BL, Han L, Vives L, O'Roak BJ, Sudmant PH, Shendure J, Abney M, Ober C, et al. 2012. Estimating the human mutation rate using autozygosity in a founder population. Nat Genet 44:1277-1281.
12. Cancer Genome Atlas Network. 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474:609-615.
13. Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337.
14. Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN. 2005a. Complex gene rearrangements caused by serial replication slippage. Hum Mutat 26:125-134.
15. Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN. 2005b. Intrachromosomal serial replication slippage in trans gives rise to diverse genomic rearrangements involving inversions. Hum Mutat 26:362-373.
16. Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN. 2005c. Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage. Hum Mutat 25:207-221.
17. Chen JM, Stenson PD, Cooper DN, Férec C. 2005d. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 117:411-427.
18. Chen JM, Cooper DN, Chuzhanova N, Férec C, Patrinos GP. 2007. Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet 8:762-775.
19. Chen JM, Férec C, Cooper DN. 2009. Closely spaced multiple mutations as potential signatures of transient hypermutability in human genes. Hum Mutat 30:1435-1448.
20. Chen JM, Cooper DN, Férec C, Kehrer-Sawatzki H, Patrinos GP. 2010. Genomic rearrangements in inherited disease and cancer. Semin Cancer Biol 20:222-233.
21. Chen CH, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, Gnatenko DV, Wu L, Turesky RJ, Wu XR, Pu YS, Grollman AP. 2012a. Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci USA 109:8241-8246.
22. Chen JM, Férec C, Cooper DN. 2012b. Transient hypermutability, chromothripsis and replication-based mechanisms in the generation of concurrent clustered mutations. Mutat Res 750:52-59.
23. 2-propanodeoxyguanosine adducts. Mutat Res 424:71-81.
24. Chuzhanova N, Chen JM, Bacolla A, Patrinos GP, Férec C, Wells RD, Cooper DN. 2009. Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat 30:1189-1198.
25. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP. 2011. Preventable exposures associated with human cancers. J Natl Cancer Inst 103:1827-1839.
26. Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F, Idaghdour Y, Hartl CL, Torroja C, Garimella KV, Zilversmit M, Cartwright R, et al. 2011. Variation in genome-wide mutation rates within and between human families. Nat Genet 43:712-714.
27. Cooper DN, Bacolla A, Férec C, Vasquez KM, Kehrer-Sawatzki H, Chen JM. 2011. On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease. Hum Mutat 32:1075-1099.
28. DeMarini DM. 2012. Declaring the existence of human germ-cell mutagens. Environ Mol Mutagen 53:166-172.
29. DeMarini DM, Shelton ML, Kohan MJ, Hudgens EE, Kleindienst TE, Ball LM, Walsh D, de Boer JG, Lewis-Bevan L, Rabinowitz JR, Claxton LD, Lewtas J. 2000. Mutagenicity in lung of big Blue® mice and induction of tandem-base substitutions in Salmonella by the air pollutant peroxyacetyl nitrate (PAN): predicted formation of intrastrand cross-links. Mutat Res 457:41-55.
30. Drake JW, Bebenek A, Kissling GE, Peddada S. 2005. Clusters of mutations from transient hypermutability. Proc Natl Acad Sci USA 102:12849-12854.
31. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, et al. 2012. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150:1121-1134.
32. Gu W, Zhang F, Lupski JR. 2008. Mechanisms for human genomic rearrangements. PathoGenetics 1:4.
33. Haldane JBS. 1935. The rate of spontaneous mutation of a human gene. J Genet 31:317-326.
34. Harfe BD, Jinks-Robertson S. 2000. DNA polymerase ζ introduces multiple mutations when bypassing spontaneous DNA damage in Saccharomyces cerevisiae. Mol Cell 6:1491-1499.
35. Hastings PJ, Ira G, Lupski JR. 2009. A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327.
36. Hill KA, Wang J, Farwell KD, Sommer SS. 2003. Spontaneous tandem-base mutations (TBM) show dramatic tissue, age, pattern and spectrum specificity. Mutat Res 534:173-186.
37. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, et al. 2012. A landscape of driver mutations in melanoma. Cell 150:251-263.
38. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, et al. 2012. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150:1107-1120.
39. Kazazian HH, Jr. 1999. An estimated frequency of endogenous insertional mutations in humans. Nat Genet 22:130.
40. Kloosterman WP, Tavakoli-Yaraki M, van Roosmalen MJ, van Binsbergen E, Renkens I, Duran K, Ballarati L, Vergult S, Giardino D, Hansson K, Ruivenkamp CA, Jager M, et al. 2012. Constitutional chromothripsis rearrangements involve clustered double-stranded DNA breaks and nonhomologous repair mechanisms. Cell Rep 1:648-655.
41. Kondrashov AS. 2003. Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum Mutat 21:12-27.
42. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Wong WS, Sigurdsson G, Walters GB, et al. 2012. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488:471-475.
43. Krantz ID, Colliton RP, Genin A, Rand EB, Li L, Piccoli DA, Spinner NB. 1998. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet 62:1361-1369.
44. Lee JA, Carvalho CM, Lupski JR. 2007. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235-1247.
45. Lieber MR. 2008. The mechanism of human nonhomologous DNA end joining. J Biol Chem 283:1-5.
46. Liu P, Erez A, Nagamani SC, Dhar SU, Kolodziejska KE, Dharmadhikari AV, Cooper ML, Wiszniewska J, Zhang F, Withers MA, Bacino CA, Campos-Acevedo LD, et al. 2011. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 146:889-903.
47. Liu P, Carvalho CM, Hastings PJ, Lupski JR. 2012. Mechanisms for recurrent and complex human genomic rearrangements. Curr Opin Genet Dev 22:211-220.
48. Loeb LA, Monnat RJ, Jr. 2008. DNA polymerases and human disease. Nat Rev Genet 9:594-604.
49. Lupski JR. 2007. Genomic rearrangements and sporadic disease. Nat Genet 39:S43-S47.
50. Maris JM. 2010. Recent advances in neuroblastoma. New Engl J Med 362:2202-2211.
51. Matsuda T, Bebenek K, Masutani C, Rogozin IB, Hanaoka F, Kunkel TA. 2001. Error rate and specificity of human and murine DNA polymerase η. J Mol Biol 312:335-346.
52. Michaelson JJ, Shi Y, Gujral M, Zheng H, Malhotra D, Jin X, Jian M, Liu G, Greer D, Bhandari A, Wu W, Corominas R, et al. 2012. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 151:1431-1442.
53. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149:979-993.
54. Parkin DM. 2011. 2. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer 105(Suppl 2):S6-S13.
55. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. 2002. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435-7451.
56. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, et al. 2013. The genetic landscape of high-risk neuroblastoma. Nat Genet 45:279-284.
57. Rosenfeld JA, Malhotra AK, Lencz T. 2010. Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing. Nucleic Acids Res 38:6102-6111.
58. Sharma S, Helchowski CM, Canman CE. 2012. The roles of DNA polymerase zeta and the Y family DNA polymerases in promoting or preventing genome instability. Mutat Res, doi: 10.1016/j.mrfmmm.2012.11.002.
59. Sheen CR, Jewell UR, Morris CM, Brennan SO, Férec C, George PM, Smith MP, Chen JM. 2007. Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication. Hum Mutat 28:1198-1206.
60. Stenson PD, Ball EV, Mort M, Phillips AD, Shaw K, Cooper DN. 2012. The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protoc Bioinformatics Chapter 1:Unit 1 13.
61. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144:27-40.
62. Stone JE, Lujan SA, Kunkel TA. 2012. DNA polymerase zeta generates clustered mutations during bypass of endogenous DNA lesions in Saccharomyces cerevisiae. Environ Mol Mutagen 53:777-786.
63. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157-1160.
64. Sun JX, Helgason A, Masson G, Ebenesersdottir SS, Li H, Mallick S, Gnerre S, Patterson N, Kong A, Reich D, Stefansson K. 2012. A direct characterization of human mutation based on microsatellites. Nat Genet 44:1161-1165.
65. Sutton MD. 2010. Coordinating DNA polymerase traffic during high and low fidelity synthesis. Biochim Biophys Acta 1804:1167-1179.
66. van Loon B, Hubscher U. 2009. An 8-oxo-guanine repair pathway coordinated by MUTYH glycosylase and DNA polymerase λ. Proc Natl Acad Sci USA 106:18201-18206.
67. Zhong X, Garg P, Stith CM, Nick McElhinny SA, Kissling GE, Burgers PM, Kunkel TA. 2006. The fidelity of DNA synthesis by yeast DNA polymerase zeta alone and with accessory proteins. Nucleic Acids Res 34:4731-4742.